Skip to main content
Full access
CLINICAL SYNTHESIS
Published Online: 1 July 2009

Quick Reference Psychosomatic Medicine: Med-Psych Drug-Drug Interactions Update An Overview of Psychotropic Drug-Drug Interactions

Abstract

Source: Sandson NB, Armstrong SC, Cozza KL: Med-Psych Drug-Drug Interactions Update An Overview of Psychotropic Drug-Drug Interactions. Psychosomatics 2005;46:464–494. Reprinted with permission. Please refer to the full article for specific citations of each interaction.
The psychotropic drug-drug interactions most likely to be relevant to psychiatrists' practices are examined. The metabolism and the enzymatic and P-glycoprotein inhibition/induction profiles of all antidepressants, antipsychotics, and mood stabilizers are described; all clinically meaningful drug-drug interactions between agents in these psychotropic classes, as well as with frequently encountered nonpsychotropic agents, are detailed; and information on the pharmacokinetic/pharmacodynamic results, mechanisms, and clinical consequences of these interactions is presented. Although the range of drug-drug interactions involving psychotropic agents is large, it is a finite and manageable subset of the much larger domain of all possible drug-drug interactions. Sophisticated computer programs will ultimately provide the best means of avoiding drug-drug interactions. Until these programs are developed, the best defense against drug-drug interactions is awareness and focused attention to this issue.

Appendix 1. Significant Drug-Drug Interactions Involving Antidepressants

Appendix 1. Significant Drug-Drug Interactions Involving Antidepressants

Appendix 2. Significant Drug-Drug Interactions Involving Antipsychotics

Appendix 2. Significant Drug-Drug Interactions Involving Antipsychotics

Appendix 3. Significant Drug-Drug Interactions Involving Mood Stabilizers

Appendix 3. Significant Drug-Drug Interactions Involving Mood Stabilizers

Appendix 4. Significant Drug-Drug Interactions Involving Other Psychotropic Agents and Nonpsychotropic Agents

Appendix 4. Significant Drug-Drug Interactions Involving Other Psychotropic Agents and Nonpsychotropic Agents

Information & Authors

Information

Published In

History

Published online: 1 July 2009
Published in print: Summer 2009

Authors

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Focus

PPV Articles - Focus

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share